Finance

Lists
1752:TPE
Nang Kuang Pharmaceutical Co Ltd
NT$31,40
+0,32%
(+0,10) 1D
22 Sep., 13:30:00 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1752...
Open
NT$31,30
High
NT$31,50
Low
NT$31,30
Mkt. cap
3,17 mjd
Avg. vol.
39,65 k
Volume
32,42 k
Dividend
5,10%
Quarterly dividend
NT$0,40
Ex-dividend date
02 Jul. 2026
P/E ratio
15,47
52-wk high
NT$39,55
52-wk low
NT$31,10
EPS
NT$2,03
No. of employees
552
Open
NT$31,30
High
NT$31,50
Low
NT$31,30
Mkt. cap
3,17 mjd
Avg. vol.
39,65 k
Volume
32,42 k
Dividend
5,10%
Quarterly dividend
NT$0,40
Ex-dividend date
02 Jul. 2026
P/E ratio
15,47
52-wk high
NT$39,55
52-wk low
NT$31,10
EPS
NT$2,03
No. of employees
552
About Nang Kuang Pharmaceutical Co Ltd
CEO-
Employees552
Founded1963
Headquarters-
SectorPharmaceutical industry
Websitenangkuang.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
523,84 m
517,20 m
529,63 m
538,59 m
Cost of goods sold
356,02 m
336,54 m
342,12 m
340,37 m
Cost of revenue
356,02 m
336,54 m
342,12 m
340,37 m
Research and development expenses
41,35 m
38,21 m
38,12 m
44,63 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75,20 m
79,31 m
78,63 m
77,50 m
Operating expense
116,55 m
117,52 m
116,75 m
122,14 m
Total operating expenses
472,56 m
454,06 m
458,87 m
462,52 m
Operating income
51,27 m
63,13 m
70,76 m
76,07 m
Other non operating income
1,56 m
5,33 m
2,12 m
2,23 m
EBT including unusual items
57,04 m
76,32 m
45,21 m
64,37 m
EBT excluding unusual items
56,65 m
71,02 m
72,46 m
75,64 m
Income tax expense
10,40 m
2,97 m
13,19 m
12,63 m
Effective tax rate
18,23%
3,90%
29,17%
19,62%
Other operating expenses
-
-
-
-
Net income
46,64 m
73,82 m
32,56 m
52,37 m
Net profit margin
8,90%
14,27%
6,15%
9,72%
Earnings per share
-
-
-
-
Interest and investment income
519,00 k
1,11 m
576,00 k
1,02 m
Interest expense
-2,23 m
-2,39 m
-2,26 m
-2,04 m
Net interest expenses
-1,71 m
-1,28 m
-1,68 m
-1,02 m
Depreciation and amortization charges
-
-
-
-
EBITDA
96,96 m
107,78 m
115,20 m
121,10 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme